Search Results for "advocacy"

ONS Chief Executive Officer Brenda Nevidjon, MSN, RN, FAAN, and members of the ONS Board of Directors from across the United States share a conversation with U.S. Representative Donna E. Shalala (D-FL) on Shalala’s role in the Institute of Medicine’s historic Future of Nursing report, how the COVID-19 coronavirus pandemic influenced global perspectives on nurses, and ways that nurses can advocate for improved healthcare policy reform.

ONS Public Affairs Director Alec Stone, MA, MPA, joins Chris Pirschel, ONS staff writer, to discuss the youth vaping epidemic, how nurses are advocating for smoking cessation, which government agencies are involved in the tobacco conversation, and where ONS stands in the fight against smoking.

ONS Public Affairs Director Alec Stone, MA, MPA, joins Chris Pirschel, ONS’s staff writer/producer, to discuss the nursing advocacy achievements of 2019, what legislation and policies will be significant in 2020, what expect during a presidential election year, and how nurses can affect the health policy conversation in 2020 and beyond.

ONS’s Public Affairs Director, Alec Stone, MA, MPA, joins Chris Pirschel, ONS staff writer, to discuss the Society’s annual Capitol Hill Days event, how ONS members are working with legislators to advocate for their patients, and ways to champion the oncology nursing profession in the health policy arena.

Richard Pazdur, MD, director of the U.S. Food and Drug Administration’s Oncology Center of Excellence (OCE), joins Lisa Kennedy Sheldon, PhD, APRN, AOCNP®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss oncology nurses’ contributions to cancer care, OCE’s initiatives, and the COVID-19 coronavirus pandemic’s implications for oncology drug approvals.  

Meet the candidates running for office on the ONS Board of Directors in the 2021 election in this bonus episode of the Oncology Nursing Podcast. Katrina Loutzenhiser, director of learning and development at ONS, explained the ONS Leadership Development Committee’s application and evaluation process, then introduced the final slate of candidates. Each candidate shared a brief message on how, as a board member, they would advance diversity, equity, and inclusion.  

ONS member Natalie Hamm, RN, MSPH, oncology nurse and health policy consultant from Arlington, VA, joins Chris Pirschel, ONS staff writer, to discuss the importance of advocacy at the local and state level, how oncology nurses can make a difference in their communities, and much more.

Alec Stone, ONS’s public affairs director in Washington, DC, joins Chris Pirschel to discuss the importance of oncology nursing advocacy, how nurses can get involved at the local and national levels, ongoing ONS events in health policy, and much more.

In this third panel discussion from ONS’s Health Policy Summit in Washington DC, Alan Balch, PhD, Patient Advocate Foundation chief executive officer, Mike Ybarra, MD, FAAEM, FACEP, vice president of medical affairs for the Pharmaceutical Research Manufacturers Association, and Jeannine Walston, a 20-year brain cancer survivor and patient advocate, discuss the challenges of tackling financial toxicity from an industry perspective, how nurses can advocate for patient resources, and much more.

Norman “Ned” Sharpless, MD, director of the National Cancer Institute (NCI), joins Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP^®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss NCI’s COVID-19 coronavirus research efforts, how the agency is partnering with oncology nurses to understand the best care for patients with COVID-19 and cancer, nursing innovation during the pandemic, and the implications of delayed screening and care on future cancer incidence rates.